Nykredit A S Buys Shares of 9,680 Docusign Inc. $DOCU

Nykredit A S purchased a new position in Docusign Inc. (NASDAQ:DOCU) in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 9,680 shares of the company’s stock, valued at approximately $430,000.

Several other large investors also recently made changes to their positions in DOCU. Smartleaf Asset Management LLC increased its holdings in shares of Docusign by 8.2% during the 2nd quarter. Smartleaf Asset Management LLC now owns 2,169 shares of the company’s stock valued at $166,000 after acquiring an additional 165 shares during the last quarter. Centaurus Financial Inc. lifted its holdings in Docusign by 3.4% in the 3rd quarter. Centaurus Financial Inc. now owns 5,582 shares of the company’s stock worth $402,000 after purchasing an additional 184 shares during the last quarter. Tred Avon Family Wealth LLC boosted its position in Docusign by 3.6% during the first quarter. Tred Avon Family Wealth LLC now owns 6,176 shares of the company’s stock worth $293,000 after purchasing an additional 215 shares during the period. First Citizens Bank & Trust Co. boosted its position in Docusign by 2.1% during the first quarter. First Citizens Bank & Trust Co. now owns 11,745 shares of the company’s stock worth $557,000 after purchasing an additional 239 shares during the period. Finally, Ballentine Partners LLC grew its holdings in Docusign by 7.8% during the fourth quarter. Ballentine Partners LLC now owns 3,529 shares of the company’s stock valued at $241,000 after purchasing an additional 254 shares during the last quarter. Institutional investors own 77.64% of the company’s stock.

Docusign Stock Performance

NASDAQ DOCU opened at $65.08 on Wednesday. The firm has a 50-day simple moving average of $56.58 and a 200 day simple moving average of $50.21. Docusign Inc. has a twelve month low of $40.16 and a twelve month high of $86.65. The stock has a market cap of $12.43 billion, a PE ratio of 39.68, a PEG ratio of 2.43 and a beta of 0.90.

Docusign (NASDAQ:DOCU) last issued its quarterly earnings results on Thursday, September 3rd. The company reported $1.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.09 by $0.07. The firm had revenue of $875.75 million for the quarter, compared to analyst estimates of $867.22 million. Docusign had a return on equity of 18.29% and a net margin of 9.82%.The company’s quarterly revenue was up 9.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.30 earnings per share. Research analysts forecast that Docusign Inc. will post 2.03 earnings per share for the current fiscal year.

Insider Buying and Selling at Docusign

In other Docusign news, Director James A. Beer sold 450 shares of Docusign stock in a transaction on Friday, August 28th. The shares were sold at an average price of $64.02, for a total transaction of $28,809.00. Following the sale, the director owned 14,586 shares in the company, valued at $933,795.72. The trade was a 2.99% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CRO Paula Hansen sold 6,000 shares of the business’s stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $45.54, for a total transaction of $273,240.00. Following the completion of the sale, the executive directly owned 89,972 shares in the company, valued at $4,097,324.88. This trade represents a 6.25% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 135,602 shares of company stock valued at $7,407,299 in the last quarter. 0.59% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on DOCU. Evercore set a $65.00 price target on shares of Docusign in a research report on Friday. Wells Fargo & Company raised their target price on shares of Docusign from $55.00 to $60.00 and gave the company an “equal weight” rating in a research note on Friday. Weiss Ratings upgraded shares of Docusign from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, August 25th. UBS Group boosted their target price on shares of Docusign from $54.00 to $70.00 and gave the stock a “neutral” rating in a research report on Friday, September 4th. Finally, Bank of America upped their price target on shares of Docusign from $58.00 to $64.00 and gave the company an “underperform” rating in a report on Friday, September 4th. Three research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $67.33.

Docusign Profile

Docusign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, Docusign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, Docusign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

Docusign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.